Trimodality Therapy for Malignant Pleural Mesothelioma

Annals of Thoracic Surgery

Volumn 88, Issue 3, 2009, Pages 870-876

  Buduhan, Gordon ^a   Menon, Shekhar ^a   Aye, Ralph ^a   Louie, Brian ^a   Mehta, Vivek ^a   Vallières, Eric ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; METHOTREXATE; PEMETREXED; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL RATE; WASHINGTON;

EID: 68849083234     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.05.036     Document Type: Article

References (22)

1. Sugarbaker D., Mentzer S., DeCamp M., et al. Extrapleural pneumonectomy in the setting of a multimodality approach to malignant mesothelioma. Chest 103 (1993) 377-381S
2. Sugarbaker D., Flores R., Jaklitsch M., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
3. Flores R., Krug L., Rosenzweig K., et al. Induction chemotherapy, extrapleural pneumonectomy and postoperative high-dose radiatiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1 (2006) 289-295
4. Rea F., Marulli G., Bortolotti L., et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemithoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 57 (2007) 89-95
5. Weder W., Stahel R., Bernhard J., et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202
6. Opitz I., Kestenholz P., Lardinois D., et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothor Surg 29 (2006) 579-584
7. Hunt K., Longton G., and Williams M. Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy. Chest 109 (1996) 1239-1242
8. Vogelzang N., Rusthoven J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
9. Butchart E., Ashcroft T., Barnsley W., and Holden M. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax 31 (1976) 15-24
10. Roberts J., Eustis C., Devore R., et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
11. Maggi G., Casadio C., Cianci R., et al. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothor Surg 19 (2001) 346-350
12. Pagan V., Ceron L., Paccagnella A., and Pizzi G. 5 year prospective results of trimodality treatment for malignant pleural mesothelioma. J Cardiovasc Surg 47 (2006) 595-601
13. Batirel H., Metintas M., Caglar H., et al. Trimodality treatment of malignant pleural mesothelioma. J Thorac Oncol 3 (2008) 499-504
14. Rusch V., Rosenzweig K., Venkatraman E., et al. A phase II trial of surgical resection and adjuvant high dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
15. Yajnik S., Rosenzweig K., Mychalczak B., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. J Radiat Oncol Biol Phys 56 (2003) 1319-1326
16. Rice D., Smythe W., Liao Z., et al. Dose dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69 (2007) 350-357
17. Miles E., Larrier N., Kelsey C., et al. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys 71 (2008) 1143-1150
18. Allen A., Czerminska M., Janne P., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
19. Rice D., Stevens C., Correa A., et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84 (2007) 1685-1693
20. Mineo T., Ambroqi V., Pompeo E., et al. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma. Ann Thorac Surg 85 (2008) 1740-1746
21. Merritt N., Blewett C., Miller J., et al. Survival after conservative (palliative) management of malignant pleural mesothelioma. J Surg Onc 78 (2001) 171-174
22. Peto J., Denholm E., Waller D., et al. Annual National Meeting of the British Thoracic Oncology Group: the MARS (mesothelioma and radical surgery) Trial (2003)